Free Newsletter
Cancer stem cells needed for metastatic growth
Researchers from Ludwig-Maximilians-University in Munich have determined that cancer stem cells govern metastasis in pancreatic cancer as well as making tumors resistant to chemotherapy. Patrick Hermann and colleagues focused specifically on pancreatic cancer, but scientists in the field say that it's a validation of other research that has identified a specific set of stem cells as playing a pivotal role in advancing a variety of cancers. Cancer stem cells are characterized by the cell surface antigen CD133. A subset of CD133 cells formed tumors and metastases when injected into mice. Compounds that attack these specific cells could play a big role in future anti-cancer therapies.
- read the article from The Scientist
Comments
Post new comment
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
SHARE
WITH: